- Home
- MRBK vs NVCT Comparison
MRBK vs NVCT Comparison
Compare MRBK & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRBK | NVCT |
|---|---|---|
| Founded | 2004 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.4M | 220.0M |
| IPO Year | 2017 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MRBK | NVCT |
|---|---|---|
| Price | $18.30 | $8.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $18.00 | $15.33 |
| AVG Volume (30 Days) | 68.8K | ★ 72.3K |
| Earning Date | 01-23-2026 | 02-24-2026 |
| Dividend Yield | ★ 2.73% | N/A |
| EPS Growth | ★ 75.95 | N/A |
| EPS | ★ 1.77 | N/A |
| Revenue | ★ $109,758,000.00 | N/A |
| Revenue This Year | $26.48 | N/A |
| Revenue Next Year | $7.79 | N/A |
| P/E Ratio | $10.36 | ★ N/A |
| Revenue Growth | ★ 18.84 | N/A |
| 52 Week Low | $11.16 | $5.55 |
| 52 Week High | $19.24 | $11.52 |
Technical Indicators
Market Signals| Indicator | MRBK | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 57.50 | 54.21 |
| Support Level | $18.10 | $8.08 |
| Resistance Level | $19.24 | $8.93 |
| Average True Range (ATR) | 0.47 | 0.46 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 52.31 | 31.77 |
Price Performance
Historical ComparisonAbout MRBK Meridian Corporation
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.